clarithromycin has been researched along with glycolipids in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, GP; Chavez, VE; Franzblau, SG; Garcia-Ignacio, BY; Jimenez, CL; Livelo, JB; Parrilla, ML | 1 |
| Chen, X; Hu, H; Hu, P; Li, H; Li, P; Shen, Y; Yuan, G; Zou, Y | 1 |
| Chen, X; Hu, H; Li, P; Shen, Y; Yuan, G; Zou, Y | 1 |
1 trial(s) available for clarithromycin and glycolipids
| Article | Year |
|---|---|
Clinical trial of clarithromycin for lepromatous leprosy.
Topics: Adolescent; Adult; Animals; Antigens, Bacterial; Clarithromycin; Foot; Glycolipids; Humans; Leprosy, Lepromatous; Male; Mice; Middle Aged; Mycobacterium leprae; Spirometry | 1994 |
2 other study(ies) available for clarithromycin and glycolipids
| Article | Year |
|---|---|
Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Biopolymers; Cell Adhesion; Cell Line, Tumor; Chitosan; Clarithromycin; Glycolipids; Helicobacter pylori; Humans; Mucus; Nanoparticles; Polyethylene Glycols | 2019 |
Rhamnolipid-involved antibiotics combinations improve the eradication of Helicobacter pylori biofilm in vitro: A comparison with conventional triple therapy.
Topics: Amoxicillin; Biofilms; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycolipids; Helicobacter pylori; Microbial Sensitivity Tests; Microbial Viability; Proton Pump Inhibitors | 2019 |